2m 2m 2m 2m 2m 2m 2m
LIPOCINE (LPCN)
NASDAQ
$2.35$0.00 (0.00%)
Price as of Jul 14, 2026 4:00 AM EDT- $19.4MMarket Cap
- -26.56%1-Year Change
- BiotechnologyIndustry
LIPOCINE (LPCN)
$2.35$0.00 (0.00%)
LPCN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.35 | ||
Change | -$0.06 (-2.49%) | ||
Open | $2.39 | ||
High | $2.45 | ||
Low | $2.32 | ||
Previous Close | $2.41 | ||
Volume | 37,232 | ||
30-Day Average Volume | 69,131 | ||
1-Week Change | -4.86% | ||
1-Month Change | 3.98% | ||
1-Year Change | -26.56% | ||
3-Year Change | -47.43% | ||
5-Year Change | -89.53% | ||
Fundamentals | |||
Shares Outstanding | 8.2M | ||
Total Assets | $25.4M | ||
Market Cap | $19.4M | ||
Enterprise Value | $14.4M | ||
Period: QTR TTM FY | |||
Revenue | $119,397.00 | ||
Net Income | -$3.7M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$3.7M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $22.7M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 120 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 17 | ||
Last Split Date | 05/12/2023 | ||
Earnings & Revenue